Site-Specific Enzymatic Radiofluorination of Biomolecules: From Current Methodologies to Emerging Opportunities

Abstract The recent expansion of recombinant biomolecules as diagnostic and therapeutic agents has created a strong need for mild, site-specific, and universally applicable methods to radiolabel them for positron emission tomography (PET). Fluorine-18 is one of the most widely used radionuclides for PET because it combines a clinically practical half-life, high positron intensity with low mean energy, and a non-metallic footprint in the label. However, the conditions necessary for efficient nucleophilic fluorine-18 radiolabelingbasic, anhydrous media, elevated temperature, and aprotic solventsare poorly compatible with sensitive biomolecules. Therefore, prosthetic group labeling with subsequent conjugation, both site-specific and non-site-specific, and aluminum-[18F]fluoride (Al[18F]F2+) chelation have become essential workarounds. Depending on the radiolabeling site, this can yield heterogeneous products, with impaired tracer target binding and pharmacokinetics. Enzymatic ligation offers a complementary strategy, with radiofluorination done on a robust small-molecule or peptide substrate, and subsequently, an enzyme catalyzes a mild and site-specific conjugation to a genetically encoded recognition motif on the target. This ensures that each step proceeds under its own optimal conditions. This review evaluates the current state of enzymatic and chemoenzymatic radiofluorination of biomolecules, from the early fluorinase work to recent advances with lipoic acid ligase (LplA), peptide asparaginyl ligase, and sortase A (SrtA). It further reviews enzymes and techniques that could extend this toolbox. The field is still emerging, but available evidence suggests that enzyme-mediated radiofluorination can occupy a niche between classical prosthetic-group radiochemistry and kit-like radiometal labeling, especially for fragile recombinant biomolecules whose radiolabeling with fluorine-18 is currently a challenge.

Authors

Institutions

Publication Details

Journal
Bioconjugate Chemistry
Published
2026-11-16
DOI
https://doi.org/10.1021/acs.bioconjchem.6c00414
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Site-Specific Enzymatic Radiofluorination of Biomolecules: From Current Methodologies to Emerging Opportunities

Jessica Bridoux, Mirkka P. Sarparanta, Sofie Declercq, Jan Brokemper et al.
Bioconjugate Chemistry
Radiopharmaceutical Chemistry and Applications
article

Site-Specific Enzymatic Radiofluorination of Biomolecules: From Current Methodologies to Emerging Opportunities

Jessica Bridoux, Mirkka P. Sarparanta, Sofie Declercq, Jan Brokemper, Nick Devoogdt
article en

Abstract

Abstract The recent expansion of recombinant biomolecules as diagnostic and therapeutic agents has created a strong need for mild, site-specific, and universally applicable methods to radiolabel them for positron emission tomography (PET). Fluorine-18 is one of the most widely used radionuclides for PET because it combines a clinically practical half-life, high positron intensity with low mean energy, and a non-metallic footprint in the label. However, the conditions necessary for efficient nucleophilic fluorine-18 radiolabelingbasic, anhydrous media, elevated temperature, and aprotic solventsare poorly compatible with sensitive biomolecules. Therefore, prosthetic group labeling with subsequent conjugation, both site-specific and non-site-specific, and aluminum-[18F]fluoride (Al[18F]F2+) chelation have become essential workarounds. Depending on the radiolabeling site, this can yield heterogeneous products, with impaired tracer target binding and pharmacokinetics. Enzymatic ligation offers a complementary strategy, with radiofluorination done on a robust small-molecule or peptide substrate, and subsequently, an enzyme catalyzes a mild and site-specific conjugation to a genetically encoded recognition motif on the target. This ensures that each step proceeds under its own optimal conditions. This review evaluates the current state of enzymatic and chemoenzymatic radiofluorination of biomolecules, from the early fluorinase work to recent advances with lipoic acid ligase (LplA), peptide asparaginyl ligase, and sortase A (SrtA). It further reviews enzymes and techniques that could extend this toolbox. The field is still emerging, but available evidence suggests that enzyme-mediated radiofluorination can occupy a niche between classical prosthetic-group radiochemistry and kit-like radiometal labeling, especially for fragile recombinant biomolecules whose radiolabeling with fluorine-18 is currently a challenge.

Bioconjugate Chemistry
University of Helsinki (FI), Vrije Universiteit Brussel (BE)
Fonds Wetenschappelijk Onderzoek, Vrije Universiteit Brussel, Helsingin Yliopiston Tiedesäätiö
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon